Ricardo Lanuza is a Los Angeles, California based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Ricardo Lanuza is 17132 for Ophthalmology in California. Ricardo Lanuza is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Ricardo Lanuza speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Gender:
Male
Practice Address:
11335 Santa Monica Blvd, Los Angeles, California, 90025-3151
Phone:
310-862-2133
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1063390805
NPI Enumeration Date:
21 Aug, 2025
NPI Last Update On:
21 Aug, 2025
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Ricardo Lanuza are as mentioned below.
License Number
Specialization
State
Status
17132
Ophthalmology
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
11335 Santa Monica Blvd, Los Angeles, California
Zip:
90025-3151
Phone Number:
310-862-2133
Fax Number:
--
Patients can reach Ricardo Lanuza at 11335 Santa Monica Blvd, Los Angeles, California or can call to book an appointment on 310-862-2133. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.